Welcome to our dedicated page for Nature's Miracle Holding SEC filings (Ticker: NMHI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tracking vertical farming breakthroughs, electric vehicle ambitions, and bitcoin-mining updates in a single disclosure set is no small task. If you’ve ever searched for "Nature's Miracle SEC filings explained simply" or needed "Nature's Miracle 8-K material events explained", you know how quickly sections pile up and acronyms blur together.
Stock Titan’s AI-powered summaries turn each "Nature's Miracle quarterly earnings report 10-Q filing" and "Nature's Miracle annual report 10-K simplified" into clear, skimmable insights. Real-time alerts flag "Nature's Miracle insider trading Form 4 transactions" the moment they reach EDGAR, while side-by-side trend charts reveal how greenhouse LED revenue or Hydroman Electric costs move over time.
Use the platform for "Nature's Miracle earnings report filing analysis", monitor "Nature's Miracle Form 4 insider transactions real-time", or dive into "Nature's Miracle executive stock transactions Form 4" without getting lost in footnotes. Need compensation details? The "Nature's Miracle proxy statement executive compensation" tab highlights pay packages against performance metrics, and interactive guides for "understanding Nature's Miracle SEC documents with AI" show exactly where to find segment-specific cash-flow data. All form types, updated instantly, in one place.
Nature’s Miracle Holding Inc. (NMHI) reported that shareholders holding approximately 98.6% of voting power approved by written consent two actions: authorizing the Board to implement a reverse stock split at a ratio between 1:5 and 1:20, and amending the Certificate of Incorporation to increase authorized common shares from 100,000,000 to 1,000,000,000.
The reverse split, if effected after the required 20-day notice period, would reduce outstanding shares proportionally; for example, at 1:10, outstanding common would move from 13,955,251 to 1,395,525 shares. Fractional shares will be rounded down to the next whole share. The Board may choose any whole-number ratio within the approved range or abandon the split at its discretion.
The company states the primary purposes are to support potential exchange listing requirements, broaden investor access, and provide flexibility for financings. The authorized share increase is intended in part to facilitate an equity line with GHS Investments for up to 55,817,669 shares under a
Nature’s Miracle Holding Inc. (NMHI)$72,377 from $3.1 million a year earlier, as gross profit was essentially breakeven and operating expenses of $1.3 million drove an operating loss of $1.3 million. After $0.8 million of net other expense, mainly interest and financing costs, the company posted a quarterly net loss of $2.2 million, and a nine‑month net loss of $6.0 million.
Cash and cash equivalents were just $61,450 with a working capital deficit of about $19.0 million, total liabilities of $30.2 million, and a stockholders’ deficit of $8.9 million as of September 30, 2025. Management discloses that recurring losses, negative operating cash flow of $1.8 million for the nine months, and heavy debt raise “substantial doubt” about the company’s ability to continue as a going concern.
During the period the company used equity, preferred stock and convertible notes for financing and completed a $17.5 million related‑party acquisition of Zak Properties’ Ohio real estate, increasing property and equipment to $17.1 million from $4.2 million. NMHI also notes access to a $20 million equity line and several new funding agreements, but future financing remains uncertain.
Nature’s Miracle Holding Inc. (NMHI) entered financing and governance agreements. The company agreed to sell up to 2,000 shares of Series D Preferred Stock at
Separately, NMHI and GHS Investments LLC entered an agreement for 50 shares of Series A Preferred Stock in consideration of the investor’s consent to previously disclosed actions, including issuing 5,000 shares of Series B (with 20‑to‑1 super voting rights), 9,500 shares of Series C for an asset acquisition from CEO James Li, and a
Nature's Miracle Holding Inc. filed an 8-K disclosing corporate actions dated